Steven Inglis

Steven Inglis is a Communications Director and Communications Team Leader at Oxford PharmaGenesis since March 2018, with prior experience as a freelance medical writer and communications consultant. With a strong foundation in medical writing, Steven has expertise across various therapy areas, including cardiovascular diseases, oncology, and rare diseases. Having held multiple roles at PharmaGenesis London, Steven has developed skills in good publication practice, strategic planning, and business development. Earlier in the career, Steven worked as a postdoctoral researcher at the University of Oxford and UNSW Australia, focusing on biophysical studies of antifreeze proteins. Steven holds a PhD in Medicinal and Pharmaceutical Chemistry and has published academic research.